160 related articles for article (PubMed ID: 37390382)
1. Erratum: State of the Art: Multidisciplinary Management of Oligometastatic Renal Cell Carcinoma.
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390038CX1. PubMed ID: 37390382
[No Abstract] [Full Text] [Related]
2. State of the Art: Multidisciplinary Management of Oligometastatic Renal Cell Carcinoma.
Dason S; Lacuna K; Hannan R; Singer EA; Runcie K
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390038. PubMed ID: 37253211
[TBL] [Abstract][Full Text] [Related]
3. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions.
Donini M; Buti S; Massari F; Mollica V; Rizzo A; Montironi R; Bersanelli M; Santoni M
Expert Rev Anticancer Ther; 2020 Jun; 20(6):491-501. PubMed ID: 32479120
[TBL] [Abstract][Full Text] [Related]
4. Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib.
Lu X; Gu W; Zhang H; Zhu Y; Shi G; Ye D
Oncotarget; 2016 May; 7(18):26879-87. PubMed ID: 27058898
[TBL] [Abstract][Full Text] [Related]
5. Approaches to Oligometastatic Renal Cell Carcinoma.
Magne N; Milhade N; Sargos P; Bouleftour W
Curr Oncol Rep; 2023 Apr; 25(4):251-256. PubMed ID: 36808558
[TBL] [Abstract][Full Text] [Related]
6. The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d'Aosta multidisciplinary team.
Denaro N; Succo G; Ostellino O; Airoldi M; Merlano MC; Badellino S; Solinas C; Garrone O; Iorio GC
Crit Rev Oncol Hematol; 2023 May; 185():103968. PubMed ID: 36965646
[TBL] [Abstract][Full Text] [Related]
7. Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted
Meyer AR; Carducci MA; Denmeade SR; Markowski MC; Pomper MG; Pierorazio PM; Allaf ME; Rowe SP; Gorin MA
Ann Nucl Med; 2019 Aug; 33(8):617-623. PubMed ID: 31147927
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
Miyawaki T; Kenmotsu H; Harada H; Ohde Y; Chiba Y; Haratani K; Okimoto T; Sakamoto T; Wakuda K; Ito K; Uemura T; Sakata S; Kogure Y; Nishimura Y; Nakagawa K; Yamamoto N
BMC Cancer; 2021 Oct; 21(1):1121. PubMed ID: 34663250
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease.
Alongi F; Arcangeli S; Triggiani L; Mazzola R; Buglione di Monale E Bastia M; Fersino S; Baiguini A; Jereczek-Fossa BA; Magrini SM;
Crit Rev Oncol Hematol; 2017 Sep; 117():48-56. PubMed ID: 28807235
[TBL] [Abstract][Full Text] [Related]
10. The "new" oligometastatic disease state and associated therapies in non-small cell lung cancer: A narrative review.
Na KJ; Kim YT
J Surg Oncol; 2023 Feb; 127(2):282-287. PubMed ID: 36464990
[TBL] [Abstract][Full Text] [Related]
11. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
Iyengar P; All S; Berry MF; Boike TP; Bradfield L; Dingemans AC; Feldman J; Gomez DR; Hesketh PJ; Jabbour SK; Jeter M; Josipovic M; Lievens Y; McDonald F; Perez BA; Ricardi U; Ruffini E; De Ruysscher D; Saeed H; Schneider BJ; Senan S; Widder J; Guckenberger M
Pract Radiat Oncol; 2023; 13(5):393-412. PubMed ID: 37294262
[TBL] [Abstract][Full Text] [Related]
13. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
Kroese TE; van Rossum PSN; Nilsson M; Lordick F; Smyth EC; Rosati R; Nafteux P; D'Ugo D; Chaudry MA; Polkowkski W; Roviello F; Gockel I; Kolodziejczyk P; Haustermans K; Guckenberger M; Nordsmark M; Hawkins MA; Cervantes A; Fleitas T; van Cutsem E; Moehler M; Wagner AD; van Laarhoven HWM; van Hillegersberg R;
Eur J Surg Oncol; 2023 Jan; 49(1):21-28. PubMed ID: 36184420
[TBL] [Abstract][Full Text] [Related]
14. Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards.
Christ SM; Heesen P; Muehlematter UJ; Pohl K; William Thiel G; Willmann J; Ahmadsei M; Kroese TE; Mayinger M; Balermpas P; Wicki A; Andratschke N; Huellner M; Guckenberger M
Clin Transl Radiat Oncol; 2023 Jan; 38():123-129. PubMed ID: 36420098
[TBL] [Abstract][Full Text] [Related]
15. American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.
Amini A; Verma V; Simone CB; Chetty IJ; Chun SG; Donington J; Edelman MJ; Higgins KA; Kestin LL; Movsas B; Rodrigues GB; Rosenzweig KE; Rybkin II; Slotman BJ; Wolf A; Chang JY
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):361-375. PubMed ID: 34571054
[TBL] [Abstract][Full Text] [Related]
16. Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma.
Nagaraja H; Srivatsa N; Hemalatha S; Shweta S; Raghunath SK
Indian J Surg Oncol; 2018 Mar; 9(1):105-109. PubMed ID: 29563747
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma.
Khaddour K; Zhou A; Butt O; Huang J; Ansstas G
Front Oncol; 2023; 13():1276729. PubMed ID: 37799464
[TBL] [Abstract][Full Text] [Related]
18. Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective Trials.
Baydoun A; Lee VL; Biswas T
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358757
[TBL] [Abstract][Full Text] [Related]
19. Optimal management of oligometastatic nasopharyngeal carcinoma.
Liu H; Yang P; Jia Y
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):567-576. PubMed ID: 34089384
[TBL] [Abstract][Full Text] [Related]
20. Role of Surgery in Metastatic Renal Cell Carcinoma.
Nolazco JI; Chang SL
Hematol Oncol Clin North Am; 2023 Oct; 37(5):893-905. PubMed ID: 37330346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
